title: Neural distribution of nonapeptide binding sites in two species of songbird.
abstract: Vasotocin (VT) and its mammalian homologue, vasopressin (VP), modulate many social behaviors in a variety of vertebrate species. In songbirds, the effects of centrally administered VT vary according to species, which may reflect species-specific distributions of VT binding sites. Different radioligands used to map receptors in previous autoradiographical studies have revealed nonoverlapping distributions of VT binding, suggesting a heterogeneous population of more than one type of VT receptor. For two model songbird species, the white-throated sparrow (Zonotrichia albicollis) and zebra finch (Taeniopygia guttata), we labeled putative VT receptors with two radioligands, [(125)I]ornithine vasotocin analog ([(125)I]OVTA) and [(125)I]linear VP antagonist ([(125)I]HO-LVA). Competitive binding assays in the lateral septum showed that both ligands were effectively displaced by both VT and a related nonapeptide, mesotocin (MT), showing that these radioligands, which were developed to label mammalian nonapeptide receptors, label at least one population of related receptors in songbirds. [(125)I]OVTA labeled receptors throughout the telencephalon, diencephalon, midbrain, and brainstem, with a similar distribution in both species. In contrast, the binding of [(125)I]HO-LVA was restricted to the septal area, dorsal arcopallium, and optic tectum in sparrow and was essentially undetectable in zebra finch. Because the avian brain is likely to express multiple types of VT receptors, we hypothesize that the binding patterns of these radioligands represent a heterogeneous receptor population.
authors.affiliation: Department of Psychology, Emory University, Atlanta, Georgia 30322, USA. chleung@emory.edu
authors.forename: Cary H
authors.initials: CH
authors.lastname: Leung
authors.forename: Christopher T
authors.initials: CT
authors.lastname: Goode
authors.forename: Larry J
authors.initials: LJ
authors.lastname: Young
authors.forename: Donna L
authors.initials: DL
authors.lastname: Maney
mesh_terms: D000818:Animals; D001345:Autoradiography; D001921:Brain / Q000033:anatomy & histology*; D005260:Female; D007150:Immunohistochemistry; D008297:Male; D009474:Neurons / Q000166:cytology / Q000378:metabolism*; D009842:Oligopeptides / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology; D016133:Polymerase Chain Reaction; D017483:Receptors, Vasopressin / Q000819:agonists / Q000378:metabolism*; D012737:Sex Factors; D020308:Songbirds; D013045:Species Specificity; D014018:Tissue Distribution / Q000502:physiology; D014667:Vasopressins / Q000037:antagonists & inhibitors / Q000378:metabolism; D014668:Vasotocin / Q000008:administration & dosage / Q000819:agonists / Q000031:analogs & derivatives / Q000378:metabolism* / Q000494:pharmacology
chemical_list: D009842:Oligopeptides; D017483:Receptors, Vasopressin; C098114:hydroxyphenylacetyl-methyltyrosyl-phenylalanyl-glutaminyl-asparaginyl-arginyl-prolyl-argininamide; C034862:vasotocin receptor; D014667:Vasopressins; C076093:vasotocin, (beta-mercapto-beta,beta-cyclopentamethylenepropionic acid)-O-methyl-Tyr(2)-Thr(4)-Orn(8)-Tyr(9)-NH2; D014668:Vasotocin